Somatic Symptom Disorder in Taiwan: Integrating Psychopathology, Neurobiology, and Health Policy Perspectives
Somatic symptom disorder (SSD), formally introduced in the DSM-5 in 2013, marked a paradigm shift from exclusion-based (“medically unexplained”) to inclusion-based (“excessive distress”) diagnostic criteria. As a diagnosis with explicit positive criteria, SSD provides a framework to empirically investigate hypotheses on cultural expressions of emotional distress—such as the lower observed prevalence of depression in East Asia and the prominence of somatic complaints.